Study S002669

Evaluation of the Efficacy and Safety of a Drinkable Nutraceutical in Improving Hair Loss in Patients Treated With GLP-1/GIP Receptor Agonists: a Double-blind, 1:1 Randomized, Placebo-controlled Study.

ClinicalTrials.gov record

Registration

Registration: NCT07484061
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: DOUBLE
Status: RECRUITING
Enrollment: 40
Start: 2026-03-16
Primary completion: 2027-05-31
Lead sponsor: Olistic Research Labs S.L.
Conditions: Telogen Effluvium
Interventions: DIETARY_SUPPLEMENT:Drinkable multifactorial food supplement containing vitamins, minerals, amino acids, plant extracts, and other bioactive compounds, formulated to support hair growth and scalp health in women +45.; OTHER:Placebo control
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Hair loss [From baseline to Day 180.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.